Normal Pressure Hydrocephalus (NPH) Registry
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Normal Pressure Hydrocephalus
- Sponsor
- Codman & Shurtleff
- Enrollment
- 343
- Primary Endpoint
- Database to describe the population of patients with NPH presenting for treatment (assessed at baseline/no safety assessment)
- Status
- Completed
- Last Updated
- 16 years ago
Overview
Brief Summary
The overall aim of the registry is to develop a longitudinal, observational database that is focused on adult patients with Normal Pressure Hydrocephalus (NPH) that can be used as a source of clinical information for individual surgeons, as well as a national data repository for scientific inquiry and publications.
Detailed Description
This is a prospective, multi-center, observational database to collect data on the characteristics, management practices, and patient outcomes of NPH patients. It will be offered to a geographically representative group of U.S. physicians who will enroll NPH patients. The physician makes his/her own clinical decisions; thus, the data captured provides current practice patterns related to diagnosis, management, and results. The registry may also assist physicians in patient follow-up and certain practice management tasks. The data collected will serve to inform the medical community on optimal care for this patient population
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient meets the diagnosis criteria for Normal Pressure Hydrocephalus
- •Patient is a candidate for a hydrocephalus shunt system, per the discretion of the investigator
- •Patient or legal representative has signed an informed consent form. Competency to sign the consent form will be left up to the discretion of the investigator
Exclusion Criteria
- •Patient is under the age of 18 years
- •Patient has a known contraindication for a shunt
- •Patient has an expected life span of less than 24 months
- •Patient has an unwillingness or inability to return for required follow-up visits
Outcomes
Primary Outcomes
Database to describe the population of patients with NPH presenting for treatment (assessed at baseline/no safety assessment)
Time Frame: End of trial
Secondary Outcomes
- To determine frequency of the various treatments for NPH and the outcomes of those treatment (assessed during surgery and at follow-up/no safety assessment)(End of trial)